Simulations Plus, Inc. (Nasdaq: SLP) ("Simulations Plus" or the "Company"), a global leader in model-informed and ...

The collaboration marks a turning point in AI-driven drug design and trial forecasting, de-risking the drug development ...

Delve into what 2026 has to offer in the biotech industry. The market is showing signs it's picking up and the patent cliff ...

The 43rd  District-Level NCORD (Narco Coordination Committee) meeting was today convened at the DC Office Budgam under the chairmanship of Deputy Commissioner Budgam, Dr. Bilal Mohi-ud-Din Bhat, to ...

Ontario teacher Amy Miller was told she would lose coverage for a drug she relies on to manage a painful condition unless she ...

For more than 60 years, this blank slate approach has been the Food and Drug Administration’s gold standard — and for good ...

Advancements in AI, multi-omics, and genome editing are transforming life sciences and biotechnology, addressing new ...

Aidoc, the pioneer and global leader of clinical AI, today announced that the U.S. Food and Drug Administration (FDA) has cleared the healthcare industry's first comprehensive AI triage solution[1],[2 ...

On January 2, 2026, the US Food and Drug Administration (FDA) began accepting statements of interest for its Technology-Enabled Meaningful ...

After passing its largest tax increase in history, the City of Regina is looking for the province to help cover growing costs ...

An internationally validated, imaging-based score helps clinicians better identify patients with stroke at highest risk for epilepsy.

RAPT Therapeutics, Inc. is being acquired by GSK plc for $2.2B as ozureprubart targets IgE disorders with 8–12 week dosing.